subscribeSubscribe
Immetas Announces Series A Financing for Cancer and Inflammatory Disease

Immetas Announces Series A Financing for Cancer and Inflammatory Disease
BUSINESSWIRE
23 Sep 2020
Share Share
Tesaro`s injected chemo nausea med Varubi can cause anaphylaxis, company warns

Tesaro`s injected chemo nausea med Varubi can cause anaphylaxis, company warns
Eric Sagonowsky FIERCE PHARMA
16 Jan 2018
Share Share
TESARO Announces U.S. FDA Approval of VARUBI® IV for Delayed Nausea & Vomiting

TESARO Announces U.S. FDA Approval of VARUBI® IV for Delayed Nausea & Vomiting
GLOBENEWSWIRE
25 Oct 2017
Share Share
Tesaro Uk Varuby (Rolapitant) Receives Approval In Europe

Tesaro Uk Varuby (Rolapitant) Receives Approval In Europe
EMA
31 May 2017
Share Share
Tesaro`s Varuby (Rolapitant) Receives Approval In Europe

Tesaro`s Varuby (Rolapitant) Receives Approval In Europe
EMA
31 May 2017
Share Share
Six new medicines endorsed for EU approval

Six new medicines endorsed for EU approval
Selina McKee PHARMATIMES
27 Feb 2017
Share Share
J&J gets CHMP backing for broader Darzalex use

J&J gets CHMP backing for broader Darzalex use
Phil Taylor PMLIVE
27 Feb 2017
Share Share
Sanofi awaits FDA inspection of fill/finish plant before Q1 Kevzara resubmission

Sanofi awaits FDA inspection of fill/finish plant before Q1 Kevzara resubmission
Dan Stanton IN PHARMATECHNOLOGIST
10 Feb 2017
Share Share
3 Potential Acquisition Targets for Gilead Sciences, Inc.

3 Potential Acquisition Targets for Gilead Sciences, Inc.
Keith Speights THE MOTLEY FOOL
16 Nov 2016
Share Share
Tesaro`s Varubi (Rolapitant) Approved in US For Nausea and Vomiting

Tesaro`s Varubi (Rolapitant) Approved in US For Nausea and Vomiting
Press Release FDA
03 Sep 2015
Share Share